Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Closure of Trading Window

 Pursuant to the Company's Code of Conduct to Regulate, Conduct, Monitor, and Report Trading by Insiders, formulated and adopted under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, duly amended, the Trading Window for dealing in shares of the Company will be closed from October 1, 2022, for Directors, Designated Persons, Insiders, and their Immediate Relatives and shall open 48 (forty-eight) hours after the financial results for the quarter and half year ended September 30, 2022, are made public.
30-09-2022
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Announcement Under Regulation 30

 Announcement under Regulation 30
23-09-2022
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Resignation Of Internal Auditor

 Resignation of Internal Auditor
21-09-2022
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Announcement under Regulation 30 (LODR)-Credit Rating

 ICRA, the credit rating agency has downgraded the long-term rating on the Rs. 176 crs bank facilities of the Company to [ICRA] A- (Stable) (pronounced ICRA A minus with a Stable outlook). This rating indicates have adequate degree of safety regarding timely servicing of financial obligations. Such instruments carry low credit risk.
19-09-2022

Unichem gets USFDA nod for generic medication

 On Tuesday, the pharmaceutical company Unichem Laboratories said the US Food and Drug Administration (USFDA) has given the firm the go-ahead to market its medication with a 200 mg dosage.
23-08-2022
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Press release pertaining to receipt of ANDA approval from United States Food and Drug Administration (USFDA) for Unichem's Carbamazepine Tablets.
23-08-2022
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 ANDA approval from United States Food and Drug Administration (USFDA) for Unichem's Quetiapine Extended-Release Tablets USP.
16-08-2022
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Unichem Laboratories Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
11-08-2022
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 Please find the results of the voting done at the 59th AGM under Regulation 44 of LODR along with the Scrutinizer''s report.
10-08-2022
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Financial Results for quarter ended June 30, 2022 published in newspapers on August 10, 2022.
10-08-2022
Next Page
Close

Let's Open Free Demat Account